Clusterin: a key player in cancer chemoresistance and its inhibition - Wikidata - wikimedia - TriplyDB

Clusterin: a key player in cancer chemoresistance and its inhibition

Clusterin: a key player in cancer chemoresistance and its inhibition

http://www.wikidata.org/entity/Q24567925

about

sameAs

Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?Biomarkers for Primary Sjögren's Syndrome Dynamic self-guiding analysis of Alzheimer's disease.Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.Pten Regulates Epithelial Cytodifferentiation during Prostate Development.Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression.Making many from few: IL-12p40 as a model for the combinatorial assembly of heterodimeric cytokines.Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.Increased extracellular clusterin in the prefrontal cortex in schizophrenia.eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants.Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.Altered gene expression in conjunctival squamous cell carcinoma.Sequences and combinations of multifaceted therapy in advanced prostate cancer.High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren's syndrome.A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer Protection of host cells by complement regulators.Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis.Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial.Protective effect of clusterin on rod photoreceptor in rat model of retinitis pigmentosa Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target.Thirty Minutes of Hypobaric Hypoxia Provokes Alterations of Immune Response, Haemostasis, and Metabolism Proteins in Human Serum Clusterin modulates transdifferentiation of non-small-cell lung cancer.Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU.Serum Proteome in a Sporadic Amyotrophic Lateral Sclerosis Geographical Cluster.Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2/ADM cells.Understanding mechanisms and seeking cures for Alzheimer's disease: why we must be "extraordinarily diverse".Intraventricular apolipoprotein ApoJ infusion acts protectively in Traumatic Brain Injury.O-linked N-acetylglucosamine transferase enhances secretory clusterin expression via liver X receptors and sterol response element binding protein regulation in cervical cancer.Clusterin in Neuroendocrine Epithelial Neoplasms: Absence of Expression in a Well-differentiated Tumor Suggests a Jejunoileal Origin.Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.Knockdown of clusterin alters mitochondrial dynamics, facilitates necrosis in camptothecin-induced cancer stem cells.Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers

P2860

Q26781196-E7BFEC25-C03E-41B2-9ED0-C4BD63B77F44 Q26781381-E1FD5F64-3D41-4895-8413-CFD80B89D8B7 Q28080897-94806787-1817-4649-99B7-9283E3585231 Q35452689-6101916F-0650-4069-B46D-A737449F5951 Q35650240-630A6F23-7F47-4463-8799-1E9DC0075111 Q35664021-BC720E91-5C44-44BD-9735-7FD334DFB92B Q35778619-32FEB81A-8922-43E2-8BED-9CD3C2204BD2 Q36068746-A9F4DB60-F8D5-4750-B82B-517423E54ADC Q36105571-3BC0AD05-7F5D-4090-96D7-DEF0482C7E7C Q36363019-BCF2C6C3-83BE-46E9-92E4-24A92AB91376 Q36378305-80160948-AA40-41E7-8C9B-FF65228560A9 Q37109809-0E0F2972-25FC-4FEE-8FD4-7537FBDDCFDE Q37730750-EC260827-8860-4913-90BF-AAD67CBB953D Q38211968-C67E44AF-0679-4000-83DD-738062DCA809 Q38293577-58652B3C-37FA-447F-84E6-44D520E2382D Q38391800-ED928E2E-1899-4E16-BF12-513FA490AC1E Q38468546-7A67B7BC-F652-422F-8F30-0A77189DE78F Q38921522-E5D24C39-524F-4E5F-A2E9-BA1ED1DA7155 Q38991019-3BFB906F-4048-4145-B50D-0350801556C6 Q39172440-E6E2B3F4-1333-4B8D-A157-FDECF842D521 Q40112666-425472CE-9F5D-4D47-8DE8-B64EBB87EC63 Q41214333-9BC72CCC-B511-4209-A9AB-2EC2C1C734B1 Q41592701-667F58C5-213A-4785-B654-47C7A37E97F6 Q41661095-AA3525B3-1654-4F2B-9548-E6EBFCDE6D11 Q42200953-33ED8689-9E5A-4BE1-B5DD-A903C0CC7376 Q47230976-75EBD282-D930-451C-9492-18027D808CE5 Q47965356-2DB3EF7F-4C6B-4968-B365-0D6D5622F600 Q48132000-93C473DA-1C88-47A8-B016-0C9AE8930D92 Q48762558-581E7326-B999-4CA7-BB22-116FE9980688 Q49147262-D77D8C57-4046-459B-AEF9-4E236CB32F66 Q49642834-D3997D24-2814-4F9D-B018-C1205B6016D2 Q50115379-64CC82B2-9C1B-457A-A0B0-018EE2B61B61 Q51501402-79863F66-E710-4830-987A-FEF99460A9A1 Q53754732-75D42C11-8FA3-45A4-A3FF-526AB903E10F Q57947040-B2C66567-0F44-47C4-BF3C-93C15B489716

P2860

Clusterin: a key player in cancer chemoresistance and its inhibition

http://www.wikidata.org/entity/Q24567925

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clusterin: a key player in cancer chemoresistance and its inhibition

@ast

Clusterin: a key player in cancer chemoresistance and its inhibition

@en

Clusterin: a key player in cancer chemoresistance and its inhibition

@nl

type

label

Clusterin: a key player in cancer chemoresistance and its inhibition

@ast

Clusterin: a key player in cancer chemoresistance and its inhibition

@en

Clusterin: a key player in cancer chemoresistance and its inhibition

@nl

prefLabel

Clusterin: a key player in cancer chemoresistance and its inhibition

@ast

Clusterin: a key player in cancer chemoresistance and its inhibition

@en

Clusterin: a key player in cancer chemoresistance and its inhibition

@nl

P1433

Q24567925-B53C9759-A5D8-4237-8C30-2D97E5E6284E

P1476

Q24567925-375E3CC3-9F20-42EF-88AC-81C0C61613BD

P2093

Q24567925-955EC6AD-DF44-4D97-AA20-31D32D96585E

P2860

Q24567925-02CC9838-2604-4B55-8ECA-73D9117D0C7B

Q24567925-0603F2D3-A105-4719-AF43-7F0F7D8B6452

Q24567925-064399C0-F698-458F-ADC8-44EFD573E42F

Q24567925-09D53BB2-BBA3-464C-A9DA-E1853FCE7A69

Q24567925-15B3AD40-F7B8-4DEE-AE0C-D83B9104DF61

Q24567925-1BF320F7-DD37-4705-A05E-D4AFD7A4162A

Q24567925-1FB693E9-B147-4CEC-A4B0-4CD31B82CD46

Q24567925-1FF09E93-8D32-4066-B2E6-BE4B041B6269

Q24567925-208F10D3-A552-418F-8089-F08397F12137

Q24567925-22078A16-4953-4D16-94C2-23EFE5691F29

P304

Q24567925-DE846822-30A3-4547-9BCF-188B75A7C837

P31

Q24567925-0DBDDDC5-73D9-4AF6-B421-57FA4BBCD02A

P3181

Q24567925-32AD0A29-4711-4A79-8026-4AF64A76812D

P356

Q24567925-FA37383D-5C4A-4D74-A994-764B5F3F2C4F

P407

Q24567925-50010B24-C353-451F-84F8-D1466CC909DF

P478

Q24567925-25725E2B-C095-46B3-B945-A36999804DC4

P577

Q24567925-C1272EF3-2034-42C5-9BFA-3950466B30DE

P698

Q24567925-FDACF810-9C8E-4776-AACA-4366ABA4DC9C

P932

Q24567925-E72680AB-43BC-4E53-927B-3F55B6075BD9

P3181

P356

P1433

OncoTargets and Therapy

P1476

Clusterin: a key player in cancer chemoresistance and its inhibition

@en

P2093

Tomas Koltai

http://www.w3.org/2001/XMLSchema#string

P2860

Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells

Effects of clusterin over-expression on metastatic progression and therapy in breast cancer.

Advances and challenges in basic and translational research on clusterin

Zinc sensing receptor signaling, mediated by GPR39, reduces butyrate-induced cell death in HT29 colonocytes via upregulation of clusterin.

Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer.

Exon-skipping strategy by ratio modulation between cytoprotective versus pro-apoptotic clusterin forms increased sensitivity of LNCaP to cell death.

Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78.

Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer.

Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex

Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway.

P304

447-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1497729

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/OTT.S58622

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24672247

http://www.w3.org/2001/XMLSchema#string

P932

3964162

http://www.w3.org/2001/XMLSchema#string